AMR Industry Alliance
The AMR Industry Alliance is one of the largest private sector coalitions set up to ...
Back to List
Sumitomo Pharma
Sumitomo Pharma’s corporate mission is "to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide."
In line with this statement, we make efforts for global health, through providing drugs in the focus research areas of Psychiatry & Neurology, Oncology, and Regenerative medicine/Cell therapy, and conducting capacity building in developing countries and regions where the medical infrastructure need to be improved.
Currently we implement several projects targeting on maternal health, new-born health, clean water supply, and sanitation system.
COLLABORATIONS
SHOWING 4 of 4 COLLABORATIONS
See All
Access Accelerated Initiative
Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...
Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Pharma, Takeda Pharmaceutical Company Limited, UCB
Promoting Sound Child Growth Pilot Project
Improving the health of mothers and children through community health volunteer training....
Sumitomo Pharma
Global Health Innovative Technology (GHIT) Fund
Japanese-led initiative aiming to discover and advance the development of new health technologies such as...
Eisai, Astellas Pharma Inc, Chugai Pharmaceutical, Daiichi Sankyo, JPMA, Otsuka, Shionogi & Co., Ltd., Sumitomo Pharma, Takeda Pharmaceutical Company Limited
SHOWING 4 of 4 COLLABORATIONS
See All